Ibuprofen Banner

Ibuprofen, the active ingredient in Ibuprofen Banner, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It provides analgesic, antipyretic and anti‑inflammatory effects for the relief of mild to moderate pain, fever and inflammatory conditions in adults and, when appropriate, in pediatric patients. All batches are manufactured under EU GMP guidelines and undergo rigorous quality testing before release.

GNH USA supplies Ibuprofen Banner as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces pain, fever and inflammation by inhibiting prostaglandin synthesis.

- Headache: relief of tension‑type or migraine‑associated headache. - Musculoskeletal pain: reduction of pain from strains, sprains or arthritis. - Fever: lowering of elevated body temperature.

Adverse reactions may occur with ibuprofen use and should be monitored.

Common Side Effects: - Nausea: mild stomach upset may occur. - Dyspepsia: indigestion or heartburn. - Headache: transient headache. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute kidney injury, especially with dehydration. - Severe allergic reactions such as anaphylaxis or skin rash.

Use ibuprofen with caution and follow recommended safety measures.

- Assess renal function: avoid in severe renal impairment. - Avoid concurrent use with other NSAIDs: increased risk of gastrointestinal bleeding. - Use the lowest effective dose: minimize cardiovascular risk. - Limit use in pregnancy: avoid in the third trimester. - Monitor for signs of bleeding: discontinue if bleeding occurs. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Ibuprofen can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may reduce renal function. - Diuretics: risk of renal impairment. - Lithium: increased lithium levels.